1-3 of 3
Chan Yoon Cheah
Close
Sort by
Journal Articles

Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review

Clinical Trials & Observations
Edward J. Bataillard, Chan Yoon Cheah, Matthew J. Maurer, Arushi Khurana, Toby A. Eyre, Tarec Christoffer El-Galaly
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2426–2437.
https://doi.org/10.1182/bloodadvances.2021004665
Published: 2021
Includes: Supplemental data
Journal Articles

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

Clinical Trials & Observations
Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris van Vliet, Pedro Farinha, Clare Gould, Simone Birch, Laurie H. Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Jorne Biccler, Joseph M. Connors, David W. Scott, Maher K. Gandhi, Kerry J. Savage, Tarec El-Galaly, Diego Villa, Chan Yoon Cheah
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2013–2021.
https://doi.org/10.1182/bloodadvances.2019000251
Published: 2019
Journal Articles

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma

Clinical Trials & Observations
Chelsea C. Pinnix, Sarah A. Milgrom, Chan Yoon Cheah, Jillian R. Gunther, Ethan B. Ludmir, Christine F. Wogan, Loretta J. Nastoupil, Sattva S. Neelapu, Jason Westin, Hun J. Lee, Swaminathan P. Iyer, Raphael E. Steiner, Luis E. Fayad, Nathan H. Fowler, Michael L. Wang, Felipe Samaniego, Maria A. Rodriguez, Amy E. Rich, L. Jeffrey Medeiros, Bouthaina S. Dabaja
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1356–1367.
https://doi.org/10.1182/bloodadvances.2018029140
Published: 2019